Skip to main content
Top
Published in: Indian Journal of Otolaryngology and Head & Neck Surgery 2/2024

28-12-2023 | giant cell tumor | Clinical Report

Recurrent Giant Cell Tumor of Sphenoid Bone: A Rare Finding

Authors: Simran, Siddhartha Nanda, Papuji Meher, Swaroopa M Rath, Rakesh Kumar Gupta, Revathi Galeti

Published in: Indian Journal of Otolaryngology and Head & Neck Surgery | Issue 2/2024

Login to get access

Abstract

Giant Cell Tumors of the skull are rare and mostly occur in the middle cranial fossa. Radiological investigations serve as adjunct modalities; however, histopathological confirmation is mandatory. Ten to forty% of GCTs may be recurrent. Complete surgical resection is the treatment of choice, however, partial resection with adjuvant radiotherapy can serve as a secondary alternative. Recurrent cases require post-op radiotherapy. Here, we describe a case of recurrent giant cell tumor of sphenoid bone in a young male, who underwent surgical resection twice, after which he was advised adjuvant radiotherapy and denosumab. The patient did not take radiotherapy.
Literature
1.
go back to reference Freeman JL, Oushy S, Schowinsky J, Sillau S, Youssef AS (2016) Invasive giant cell Tumor of the lateral Skull Base: a systematic review, Meta-analysis, and Case Illustration. World Neurosurg 96:47–57CrossRefPubMed Freeman JL, Oushy S, Schowinsky J, Sillau S, Youssef AS (2016) Invasive giant cell Tumor of the lateral Skull Base: a systematic review, Meta-analysis, and Case Illustration. World Neurosurg 96:47–57CrossRefPubMed
2.
go back to reference Billingsley JT, Wiet RM, Petruzzelli GJ, Byrne R (2014) A locally invasive giant cell Tumor of the skull base: case report. J Neurol Surg Rep 75(1):e175–e179CrossRefPubMedPubMedCentral Billingsley JT, Wiet RM, Petruzzelli GJ, Byrne R (2014) A locally invasive giant cell Tumor of the skull base: case report. J Neurol Surg Rep 75(1):e175–e179CrossRefPubMedPubMedCentral
3.
go back to reference Leonard J et al (2001) Malignant giant-cell Tumor of the parietal bone: case report and review of the literature. Neurosurgery 48(2):424–429PubMed Leonard J et al (2001) Malignant giant-cell Tumor of the parietal bone: case report and review of the literature. Neurosurgery 48(2):424–429PubMed
5.
go back to reference van der Heijden L, Dijkstra PDS, Blay JY, Gelderblom H (2017) Giant cell tumour of bone in the denosumab era. Eur J Cancer 77:75–83CrossRefPubMed van der Heijden L, Dijkstra PDS, Blay JY, Gelderblom H (2017) Giant cell tumour of bone in the denosumab era. Eur J Cancer 77:75–83CrossRefPubMed
6.
go back to reference Antal I, Sa ́pi Z, Szendroi M (1999) The prognostic significance of DNA cytophotometry and proliferation index (Ki-67) in giant cell tumors of bone. Int Orthop 23:315–319CrossRefPubMedPubMedCentral Antal I, Sa ́pi Z, Szendroi M (1999) The prognostic significance of DNA cytophotometry and proliferation index (Ki-67) in giant cell tumors of bone. Int Orthop 23:315–319CrossRefPubMedPubMedCentral
7.
go back to reference Weng JC, Li D, Wang L, Wu Z, Wang JM, Li GL, Jia W, Zhang LW, Zhang JT (2018) Surgical management and long-term outcomes of intracranial giant cell tumors: a single-institution experience with a systematic review. J Neurosurg 131(3):695–705CrossRefPubMed Weng JC, Li D, Wang L, Wu Z, Wang JM, Li GL, Jia W, Zhang LW, Zhang JT (2018) Surgical management and long-term outcomes of intracranial giant cell tumors: a single-institution experience with a systematic review. J Neurosurg 131(3):695–705CrossRefPubMed
8.
go back to reference Malone S, O’Sullivan B, Catton C, Bell R, Fornasier V, Davis A (1995) Long-term follow-up of efficacy and safety of megavoltage radiotherapy in high-risk giant cell tumors of bone. Int J Radiat Oncol Biol Phys 33:689–694CrossRefPubMed Malone S, O’Sullivan B, Catton C, Bell R, Fornasier V, Davis A (1995) Long-term follow-up of efficacy and safety of megavoltage radiotherapy in high-risk giant cell tumors of bone. Int J Radiat Oncol Biol Phys 33:689–694CrossRefPubMed
9.
go back to reference Roux S, Amazit L, Meduri G, Guiochon-Mantel A, Milgrom E, Mariette X (2002) RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone. Am J Clin Pathol 117:210–216CrossRefPubMed Roux S, Amazit L, Meduri G, Guiochon-Mantel A, Milgrom E, Mariette X (2002) RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone. Am J Clin Pathol 117:210–216CrossRefPubMed
10.
go back to reference Luengo-Alonso G, Mellado-Romero M, Shemesh S, Ramos-Pascua L, Pretell-Mazzini J (2019) Denosumab treatment for giant-cell Tumor of bone: a systematic review of the literature. Arch Orthop Trauma Surg 139(10):1339–1349CrossRefPubMed Luengo-Alonso G, Mellado-Romero M, Shemesh S, Ramos-Pascua L, Pretell-Mazzini J (2019) Denosumab treatment for giant-cell Tumor of bone: a systematic review of the literature. Arch Orthop Trauma Surg 139(10):1339–1349CrossRefPubMed
Metadata
Title
Recurrent Giant Cell Tumor of Sphenoid Bone: A Rare Finding
Authors
Simran
Siddhartha Nanda
Papuji Meher
Swaroopa M Rath
Rakesh Kumar Gupta
Revathi Galeti
Publication date
28-12-2023
Publisher
Springer India
Published in
Indian Journal of Otolaryngology and Head & Neck Surgery / Issue 2/2024
Print ISSN: 2231-3796
Electronic ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-023-04464-z

Other articles of this Issue 2/2024

Indian Journal of Otolaryngology and Head & Neck Surgery 2/2024 Go to the issue